1. Home
  2. TECH vs WCC Comparison

TECH vs WCC Comparison

Compare TECH & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • WCC
  • Stock Information
  • Founded
  • TECH 1976
  • WCC 1922
  • Country
  • TECH United States
  • WCC United States
  • Employees
  • TECH N/A
  • WCC N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • WCC Telecommunications Equipment
  • Sector
  • TECH Health Care
  • WCC Consumer Discretionary
  • Exchange
  • TECH Nasdaq
  • WCC Nasdaq
  • Market Cap
  • TECH 7.8B
  • WCC 8.1B
  • IPO Year
  • TECH 1989
  • WCC 1999
  • Fundamental
  • Price
  • TECH $48.40
  • WCC $167.86
  • Analyst Decision
  • TECH Buy
  • WCC Buy
  • Analyst Count
  • TECH 11
  • WCC 8
  • Target Price
  • TECH $72.00
  • WCC $212.00
  • AVG Volume (30 Days)
  • TECH 2.9M
  • WCC 635.2K
  • Earning Date
  • TECH 05-07-2025
  • WCC 05-01-2025
  • Dividend Yield
  • TECH 0.66%
  • WCC 1.08%
  • EPS Growth
  • TECH N/A
  • WCC 10.34
  • EPS
  • TECH 0.83
  • WCC 13.26
  • Revenue
  • TECH $1,208,770,000.00
  • WCC $21,812,500,000.00
  • Revenue This Year
  • TECH $7.16
  • WCC $4.13
  • Revenue Next Year
  • TECH $6.36
  • WCC $4.27
  • P/E Ratio
  • TECH $58.31
  • WCC $12.66
  • Revenue Growth
  • TECH 4.72
  • WCC N/A
  • 52 Week Low
  • TECH $46.01
  • WCC $125.21
  • 52 Week High
  • TECH $83.62
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • TECH 45.79
  • WCC 52.67
  • Support Level
  • TECH $47.25
  • WCC $161.70
  • Resistance Level
  • TECH $49.92
  • WCC $175.36
  • Average True Range (ATR)
  • TECH 1.87
  • WCC 4.00
  • MACD
  • TECH 0.16
  • WCC -0.29
  • Stochastic Oscillator
  • TECH 28.14
  • WCC 41.51

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About WCC WESCO International Inc.

Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.

Share on Social Networks: